Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dennis Macejak is active.

Publication


Featured researches published by Dennis Macejak.


PLOS Pathogens | 2012

Structures of Merkel Cell Polyomavirus VP1 Complexes Define a Sialic Acid Binding Site Required for Infection.

Ursula Neu; Holger Hengel; Baerbel S. Blaum; Rachel M. Schowalter; Dennis Macejak; Michel Gilbert; Warren W. Wakarchuk; Akihiro Imamura; Hiromune Ando; Makoto Kiso; Niklas Arnberg; Robert L. Garcea; Thomas Peters; Christopher B. Buck; Thilo Stehle

The recently discovered human Merkel cell polyomavirus (MCPyV or MCV) causes the aggressive Merkel cell carcinoma (MCC) in the skin of immunocompromised individuals. Conflicting reports suggest that cellular glycans containing sialic acid (Neu5Ac) may play a role in MCPyV infectious entry. To address this question, we solved X-ray structures of the MCPyV major capsid protein VP1 both alone and in complex with several sialylated oligosaccharides. A shallow binding site on the apical surface of the VP1 capsomer recognizes the disaccharide Neu5Ac-α2,3-Gal through a complex network of interactions. MCPyV engages Neu5Ac in an orientation and with contacts that differ markedly from those observed in other polyomavirus complexes with sialylated receptors. Mutations in the Neu5Ac binding site abolish MCPyV infection, highlighting the relevance of the Neu5Ac interaction for MCPyV entry. Our study thus provides a powerful platform for the development of MCPyV-specific vaccines and antivirals. Interestingly, engagement of sialic acid does not interfere with initial attachment of MCPyV to cells, consistent with a previous proposal that attachment is mediated by a class of non-sialylated carbohydrates called glycosaminoglycans. Our results therefore suggest a model in which sialylated glycans serve as secondary, post-attachment co-receptors during MCPyV infectious entry. Since cell-surface glycans typically serve as primary attachment receptors for many viruses, we identify here a new role for glycans in mediating, and perhaps even modulating, post-attachment entry processes.


Journal of Virology | 2011

Structures of the Major Capsid Proteins of the Human Karolinska Institutet and Washington University Polyomaviruses

Ursula Neu; Jianbo Wang; Dennis Macejak; Robert L. Garcea; Thilo Stehle

ABSTRACT The Karolinska Institutet and Washington University polyomaviruses (KIPyV and WUPyV, respectively) are recently discovered human viruses that infect the respiratory tract. Although they have not yet been linked to disease, they are prevalent in populations worldwide, with initial infection occurring in early childhood. Polyomavirus capsids consist of 72 pentamers of the major capsid protein viral protein 1 (VP1), which determines antigenicity and receptor specificity. The WUPyV and KIPyV VP1 proteins are distant in evolution from VP1 proteins of known structure such as simian virus 40 or murine polyomavirus. We present here the crystal structures of unassembled recombinant WUPyV and KIPyV VP1 pentamers at resolutions of 2.9 and 2.55 Å, respectively. The WUPyV and KIPyV VP1 core structures fold into the same β-sandwich that is a hallmark of all polyomavirus VP1 proteins crystallized to date. However, differences in sequence translate into profoundly different surface loop structures in KIPyV and WUPyV VP1 proteins. Such loop structures have not been observed for other polyomaviruses, and they provide initial clues about the possible interactions of these viruses with cell surface receptors.


Archive | 2003

Rna interference by modified short interfering nucleic acid

James Mcswiggen; Leonid Beigelman; Dennis Macejak; Shawn Zinnen; Pamela Pavco; David Morrissey; Kathy Fosnaugh; Victor Mokler; Sharon Jamison


Archive | 2003

RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

James Mcswiggen; Leonid Beigelman; Dennis Macejak


Hepatology | 2000

Inhibition of hepatitis C virus (HCV)‐RNA–dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes

Dennis Macejak; Kristi Jensen; Sharon Jamison; Kristal Domenico; Elisabeth Roberts; Nilabh Chaudhary; Ira von Carlowitz; Laurent Bellon; Myron J. Tong; Andrew Conrad; Pamela Pavco; Lawrence M. Blatt


Journal of Virology | 1999

Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo.

Dennis Macejak; Hua Lin; Saiphone Webb; Jennifer Chase; Kristi Jensen; Thale C. Jarvis; Jeffrey M. Leiden; Larry Couture


Archive | 2002

Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication

Lawrence Blatt; Dennis Macejak; James Mcswiggen; David Morrissey; Pamela Pavco; Patrice Lee; Kenneth G. Draper; Elisabeth Roberts


Archive | 2003

Nucleic acid mediated disruption of hiv fusogenic peptide interactions

Dennis Macejak; Lawrence Blatt; James Mcswiggen


Archive | 2002

In vivo models for screening inhibitors of hepatitis B virus

Dennis Macejak; Patrice Lee


Archive | 1999

ENZYMATIC NUCLEIC ACIDS MOLECULES WHICH MODULATE THE EXPRESSIONS AND/OR REPLICATION OF HEPATITIS C VIRUS

Lawrence M. Blatt; James Mcswiggen; Elisabeth Roberts; Pamela Pavco; Dennis Macejak

Collaboration


Dive into the Dennis Macejak's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lawrence Blatt

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert L. Garcea

University of Colorado Boulder

View shared research outputs
Top Co-Authors

Avatar

Kristi Jensen

University of Colorado Denver

View shared research outputs
Researchain Logo
Decentralizing Knowledge